DCR

metastatic/advanced OC (mOC) - 2nd line (L2) metastatic/advanced OC (mOC) - 2nd line (L2)

versus pegylated liposomal doxorubicin
avelumab alone vs. pegylated liposomal doxorubicin 1 1684 [706; 2661] /10000
93/188 vs. 62/190